RICHMOND, VA. — Virginia recently passed a bill that would prohibit insurance companies from charging more than a $30 co-pay for a 30-day supply of insulin.
House Bill 66 was near-unanimous at 98-1. Delegate Matthew Fariss voted no, and Delegate Nick Freitas did not vote.
Outrageous prices led many who must take insulin to ration their monthly supplies or not taking the medication at all, leading to lethal consequences.
Large corporations of the world’s $27 billion insulin market, Sanofi, Eli Lilly, and Novo Nordisk, have controlled the supply since the discovery of insulin over 100 years ago.
Similar bills have recently passed in Illinois and Colorado with their caps set to $100.
A bipartisan investigation into the insulin market launched by Congress in 2019 amid a comprehensive probe into drug pricing.